Marrone Bio Innovations Engages MZ Group to Expand Investor Relations and Shareholder Communication Program
June 14 2017 - 8:30AM
Marrone Bio Innovations, Inc. (NASDAQ:MBII),
a leading provider of bio-based pest management and plant health
products for the agriculture, turf and ornamental and water
treatment markets, has engaged IR specialists MZ Group (MZ) to
manage a comprehensive strategic investor relations and financial
communications program across all key markets.
MZ will work closely with Marrone Bio Innovations’ management to
develop and execute a comprehensive strategy designed to increase
the Company’s visibility throughout the investment community. This
structured campaign will highlight Marrone Bio Innovation’s recent
business successes along with its strong intellectual property
leadership in the biopesticide space.
Marrone Bio Innovations is an industry leader in the rapidly
growing biopesticide industry, as its ability to discover and
rapidly commercialize novel products is unmatched within the
industry. The Company’s ability to “innovate at speed” in a
capital-efficient way is atypical within the ag-chem industry and
is possible because of the high safety and inherently low risk of
biopesticides. As a result of its “dual-use” approach to developing
biopesticides with biostimulant properties, Marrone Bio
Innovations’ team of scientists have developed products that
clearly differentiate the Company within the marketplace.
MZ has developed a distinguished reputation as a premier
resource for institutional investors, brokers, analysts and private
investors. The firm has six offices across North America, a strong
presence in Asia and Brazil, and maintains extensive relationships
with investors throughout Europe. Additionally, MZ was recently
ranked the No. 1 consultancy in Latin America and No. 7 in the
world in business communication.
Managing Director of MZ North America, Greg Falesnik, will be
advising Marrone Bio Innovations in all facets of corporate and
financial communications, including the coordination of roadshows
across key cities and building brand awareness with the financial
media.
“Marrone Bio Innovations welcomes its partnership with MZ Group,
the world’s largest independent IR firm. Following our strong
revenue growth and continued IP innovation across the enterprise,
we are partnering with MZ to expand and strengthen our investor
relations program,” said Pam Marrone, Marrone Bio Innovation’s
Chief Executive Officer. “MZ provides the reach and established
track record to develop and enhance our relationships with high
quality retail and institutional investors seeking investments in
the dynamic and rapidly growing biopesticide space. We are
confident that our partnership with MZ will enhance expectations of
our investor base.”
Matt Hayden, Chairman of MZ Group North America, commented, “MZ
is excited to have the opportunity to partner with a rapidly
growing IP leader like Marrone Bio Innovations. After watching the
Company concurrently grow both revenues and its intellectual
property portfolio over the last few years, we are impressed with
what Marrone Bio Innovations has been able to accomplish. Marrone
Bio Innovations provides a compelling value proposition to its
customer base, which is something that fits well into our client
portfolio. We strongly believe Marrone Bio Innovations’ value
proposition will resonate well with our investors, and when coupled
with execution, will ultimately help grow value for its
shareholders.”
About MZ GroupMZ, founded in 1999, combines
capital markets intelligence, global investor targeting, IR
technology, corporate governance, media and corporate communication
and IR consulting, providing comprehensive programs that
successfully build and manage shareholder value. With a team of
highly experienced senior professionals and an integrated service
portfolio, MZ ensures that companies are provided with the right
tools and strategies to interact effectively with the investment
community and the media, successfully conveying the investment
message. MZ's market intelligence, advisory and tactical support
activities for investor relations and corporate communications
programs are underpinned by a comprehensive IT infrastructure,
allowing companies to rapidly achieve global standards of best
practices. For more information, please visit www.mzgroup.us.
About Marrone Bio InnovationsSmart. Natural.
Solutions.Marrone Bio Innovations, Inc. (NASDAQ:MBII) strives to
lead the movement to a more sustainable world through the
discovery, development and promotion of biological products for
pest management and plant health. The Company's effective and
environmentally responsible solutions help customers operate more
sustainably while controlling pests, improving plant health, and
increasing crop yields. The Company has five products for
agriculture on the market (Regalia®, Grandevo®, Venerate®, and
Majestene® and Haven™), and also distributes Bio-tam 2.0® for
Isagro USA in the western U.S. and Jet-Ag® for Jet Harvest in most
regions of the U.S. The Company markets Zequanox® for invasive
mussels for water markets. Marrone also has a proprietary discovery
process, a rapid development platform, and a robust pipeline of
pest management and plant health product candidates. At Marrone Bio
Innovations, the Company is dedicated to pioneering better
biopesticides that support a better tomorrow for users around the
globe. For more information, please visit www.marronebio.com.
Marrone Bio Innovations Forward Looking
Statements This press release contains forward-looking
statements that involve substantial risks and uncertain-ties. All
statements, other than statements of historical facts, included in
this press release regarding strategy, future operations and plans,
including assumptions underlying such statements, are
forward-looking statements, and should not be relied upon as
representing the Company’s views as of any subsequent date.
Examples of such statements include statements regarding the
Company’s engagement with MZ, its investor relations and financial
communications program and strategy and the Company’s value
proposition. Such forward-looking statements are based on
information available to the Company as of the date of this release
and involve a number of risks and uncertainties, some beyond the
Company’s control, that could cause actual results to differ
materially from those anticipated by these forward-looking
statements, including consumer, regulatory and other factors
affecting demand for the Company’s products, competition in the
market for pest management products, lack of understanding of
bio-based pest management products by customers and growers,
adverse decisions by regulatory agencies and other relevant third
parties, and general factors affecting the capital markets.
Additional information that could lead to material changes in MBI’s
performance is contained in its filings with the SEC. MBI is under
no obligation to, and expressly disclaims any responsibility to,
update or alter forward-looking statements contained in this
release, whether as a result of new information, future events or
otherwise.
Investor Relations:
Greg Falesnik
Managing Director
MZ Group - MZ North America
(949) 385-6449
MBII@mzgroup.us
www.mzgroup.us
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Aug 2024 to Sep 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Sep 2023 to Sep 2024